AzTrials
AzTrials

Mild Traumatic Brain Injury; ConcussionSiMPlyRehabNCT03215082

Seeing-Moving-Playing: Early Rehabilitation Utilizing Visual and Vestibular Technology Following Traumatic Brain Injury

A study testing Vestibular-Visual Intervention in people with Mild Traumatic Brain Injury; Concussion, run by McGill University Health Centre/Research Institute of the McGill University Health Centre at 4 sites in 3 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this research program is to 1) Evaluate potential problems with vision, inner ear-eye reflexes and deficits of processing eye information that occur following TBI; and 2) Evaluate treatment programs for individuals with eye and inner ear problems that persist for greater than 10 days following injury. Read more about this study

Who is it for?
Ages 6 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Mild Traumatic Brain Injury; Concussion
What is being tested?
Vestibular-Visual Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
4 sitesin 3 countries
Study dates
1 Jan 2018to Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Mild TBI or moderate-severe TBI will be included

Who cannot join

  • -

Trial locations and contacts

4 sites in 3 countries.

4 sites in 3 countries

Canada2 sites, 2 recruiting
  • Sport Injury Prevention Research Centre, Faculty of Kinesiology, University of Calgary,

    Calgary, Alberta, T2N 1N4

    Kathryn Schneider, PhD, 403-210-8951, kjschnei@ucalgary.ca

    Recruiting
  • Montreal Children's Hospital, MUHC

    Montreal, Quebec, H4A3J1

    Isabelle Gagnon, PhD, 514-412-4400 ext. 23896, isabelle.gagnon8@mcgill.ca

    Recruiting

Other trials in Canada

France1 site, 1 recruiting
  • Service de Rééducation des Pathologies Neurologiques de l'Enfant - Pôle de Rééducation et Réadaptation de l'Enfant Hôpitaux de Saint Maurice

    Saint-Maurice, 94410

    Mathilde Chevignard, PhD, 01 43 96 63 40, m.chevignard@hopitaux-stmaurice.fr

    Recruiting

Other trials in France

Israel1 site, 1 recruiting
  • Department of Physical Therapy, School of Health Professions, Sackler Faculty of Medicine

    Tel Aviv

    Michal Katz-Leurer, PhD, 97236405432, michalkz@post.tau.ac.il

    Recruiting

Other trials in Israel

About this study

The aim of this research program is to 1) Evaluate potential problems with vision, inner ear-eye reflexes and deficits of processing eye information that occur following TBI; and 2) Evaluate treatment programs for individuals with eye and inner ear problems that persist for greater than 10 days following injury.

This study will include 465 youth and young adults (aged 6-30 years old) who sustain a TBI of any severity. An initial evaluative phase using the best available technology to evaluate eye and inner ear function will be performed, and compared with typical tests that are used in the clinic. If symptoms and functional problems remain 10 days after injury, participants will be randomly placed into a treatment group (including eye movement, inner ear-eye reflex and attention exercises as per our pilot studies) or a control group (typical rehabilitation). Success will be measured in terms of return to sport (mild TBI), achievement of goals (moderate and severe TBI) and quality of life. It is expected that this program will inform clinical practice and future research leading to a treatment program in TBI that includes multiple components.

Being tested
Vestibular-Visual Intervention, standard care
Medical subject headings
Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vestibular-Visual InterventionOther

    vestibular-visual exercises

  • standard careBehavioural

    standard care

Study groups in NCT03215082
Study groupRoleWhat they receive
ExperimentalExperimentalThe intervention will be an individualized impairment-based program based on a pre-determined sequence. A minimal intervention for all participants randomized to the intervention group at all sites will include general oculomotor and gaze stabilization retraining as tolerated. Intervention activities will be recorded and described in detail in a treatment log.
Receives: Other: Vestibular-Visual Intervention
ControlActive comparatorStandard care for mild TBI consists mainly of general education, energy conservation, academic adaptations, and restricting children and adolescents from participation in vigorous physical activities as well as complex cognitive activities until complete symptom resolution. It is the usual approach promoted by various associations and consensus groups. In addition, in all participating centers, children and teens requiring musculoskeletal approaches to address neck pain/dysfunction will receive it as indicated, based on the clinical judgment of the local team. Participants with moderate and severe TBI will also receive rehabilitation activities as planned in their respective centers. The standard care intervention will be recorded and described in detail in a treatment log.
Receives: Behavioral: standard care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PedsQL

    Pediatric and adult Quality of Life

    Measured: 8 weeks post intervention initiation

  2. Head Thrust Test

    Vestibulo-Ocular Reflex

    Measured: 8 weeks post-intervention initiation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jul 2017
  2. Study start1 Jan 2018
  3. Primary completionOct 2020 (estimated)
  4. Study completionDec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03215082
Sponsor's protocol ID
2018-3373
Acronym
SiMPlyRehab
Status last verified
Apr 2019
First submitted
9 Jul 2017
Last updated
5 Apr 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sorek G, Shaklai S, Gagnon I, Schneider K, Chevignard M, Stern N, Fadida Y, Kalderon L, Katz-Leurer M. Impact of Subarachnoid Hemorrhage on the Cardiac Autonomic Function During Rehabilitation in Children After Severe Traumatic Brain Injury. Neurotrauma Rep. 2023 Jul 14;4(1):458-462. doi: 10.1089/neur.2023.0032. eCollection 2023.

    PubMed 37475976
  • Sorek G, Gagnon I, Schneider K, Chevignard M, Stern N, Fadida Y, Kalderon L, Shaklai S, Katz-Leurer M. The Cardiac Autonomic Response Recovery to the Modified Tilt Test in Children Post Moderate-Severe Traumatic Brain Injury. Brain Inj. 2022 Jul 3;36(8):1033-1038. doi: 10.1080/02699052.2022.2110942. Epub 2022 Aug 15.

    PubMed 35971307
  • Sorek G, Gagnon I, Schneider K, Chevignard M, Stern N, Fadida Y, Kalderon L, Shaklai S, Katz-Leurer M. The integrated functions of the cardiac autonomic and vestibular/oculomotor systems in adolescents following severe traumatic brain injury and typically developing controls. Brain Inj. 2020 Sep 18;34(11):1480-1488. doi: 10.1080/02699052.2020.1807055. Epub 2020 Aug 18.

    PubMed 32809873

Questions about this trial

What is this clinical trial studying?

A study testing Vestibular-Visual Intervention in people with Mild Traumatic Brain Injury; Concussion, run by McGill University Health Centre/Research Institute of the McGill University Health Centre at 4 sites in 3 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Canada, France, Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Isabelle Gagnon, PhD (514-412-4400 ext. 23896, Isabelle.gagnon8@mcgill.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PedsQL (time frame: 8 weeks post intervention initiation). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03215082, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in